TARO : Summary for Taro Pharmaceutical Industries - Yahoo Finance

U.S. Markets closed

Taro Pharmaceutical Industries Ltd. (TARO)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
116.58-2.36 (-1.98%)
At close: 4:02PM EST
People also watch
SCRILCIIPXLUTHRPRGO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close118.94
Open118.20
Bid112.00 x 100
Ask0.00 x
Day's Range116.19 - 118.49
52 Week Range92.28 - 152.30
Volume29,485
Avg. Volume134,801
Market Cap4.78B
Beta0.32
PE Ratio (TTM)9.99
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Taro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: Q3, 2017 By the Numbers : February 13, 2017
    Capital Cube13 days ago

    Taro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: Q3, 2017 By the Numbers : February 13, 2017

    Categories: Yahoo Finance Get free summary analysis Taro Pharmaceutical Industries Ltd. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Taro Pharmaceutical Industries Ltd. – Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, GlaxoSmithKline plc Sponsored ADR and Novartis AG Sponsored ADR (PFE-US, MRK-US, JNJ-US, GSK-US ... Read more (Read more...)

  • Investopedia16 days ago

    Taro Pharma 3Q Net $140M Versus $189M Last Year

    Taro Pharmaceutical's third-quarter earnings and sales fell compared to last year.

  • Associated Press16 days ago

    Taro posts 3Q profit

    On a per-share basis, the Haifa Bay, Israel-based company said it had net income of $3.42. The drug maker posted revenue of $220.4 million in the period. Taro shares have climbed almost 1 percent since ...